Is REVB or RFL more undervalued in 2026?

CirclFi compares Revelation Biosciences, Inc. (REVB) and Rafael Holdings, Inc. (RFL) using 13 institutional-grade valuation models. REVB has a Quality of Company score of 4.1/10 while RFL scores 4.5/10.

Which is a better buy — REVB or RFL?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do REVB and RFL valuations compare?

REVB at $1.09 and RFL at $1.37 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

REVB vs RFL Valuation Comparison 2026 — Intrinsic Value Analysis

REVB

Pharmaceutical Preparations

Revelation Biosciences, Inc.

Quality

4.1

out of 10

Value Trap

LOW

Price

$1.09

Last close

Models

7/13

Active

RFL

Pharmaceutical Preparations

Rafael Holdings, Inc.

Quality

4.5

out of 10

Value Trap

DANGER

Price

$1.37

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	REVB Fair Value	REVB Upside	RFL Fair Value	RFL Upside
Bayesian DCF	Intrinsic	$2.19	+100.1%	$0.50	-63.4%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$5.68	+418.8%	$1.80	+31.1%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for REVB vs RFL — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

REVB vs RFL — Which Stock Is More Undervalued?

RFL scores higher with a 4.5/10 quality rating vs REVB's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Revelation Biosciences, Inc. (REVB) and Rafael Holdings, Inc. (RFL) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

REVB currently trades at $1.09 with a QOC of 4.1/10, while RFL trades at $1.37 with a QOC of 4.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).